Positioning in Wheelchair Bound Patients (AAPO'G)

August 30, 2023 updated by: FondationbHopale

Evaluation of Actions to Improve Positioning in Wheelchaire Bound Patients at Risk of Slipping : Pilot Study

The choice of the most suitable chair as well as the improvement of the patient's positioning on this wheelchair is important to limit the discomfort, to prevent the risks of bedsores, the pains related to prolonged sitting and finally to support the interaction of the patient with its environment. The goal of this prospective, longitudinale, monocentric study is to evaluate the impact of standardized positioning in wheelchair-bound patients at risk of slipping.

The main questions on the positioning actions are:

  • their actions impact of positioning actions on shear forces
  • their impact on sliding in the chair
  • their impact on the feeling of discomfort in the chair
  • their impact on the caregivers' feelings about the patient's difficulties (eating, transfers, sliding)

Participation in this study will involve an increase in the number of transfers required for shear sheet placement and removal, as well as the time required for ischial measurement and the time to complete the (Tool for Assessing Wheelchair disComfort) TAWC questionnaire.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Hauts DE France
      • Berck, Hauts DE France, France, 62608

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 76 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient hospitalized for a minimum of 9 days (minimum 48-hour reflection period after information)
  • Patient aged between 18 and 80 years,
  • Patient with a sitting time in a wheelchair > or equal to 1 hour,
  • Patient with a neurological condition : multiple sclerosis, stroke, spinal cord injury, Parkinson disease, neurodegenerative diseases...
  • Patient informed of the study and having given his written consent,

Non inclusion Criteria:

  • Cognitive disorders that do not allow the understanding of instructions
  • Patient with a pressure sore
  • Pregnant or breastfeeding woman
  • Patient under legal protection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: All patients meeting the study eligibility criteria

After a personalized analysis of the patient and his needs, the occupational therapists define the equipment necessary for the good positioning of the patient:

  • Choice and adjustments of the wheelchair
  • Choice and adjustments of the wheelchair/patient interface

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evolution of shear measurement with the Shear® sensor
Time Frame: Day 0 therefore before the implementation of the positioning actions then at Day 1 and Day 7
Shear will be measured over a period of one hour (shear evolution over one hour), during which the patient will follow a standardized activity program.
Day 0 therefore before the implementation of the positioning actions then at Day 1 and Day 7

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of the sliding distance
Time Frame: Day 0 therefore before the implementation of the positioning actions then at Day 1 and Day 7
The sliding distance is measured by the position of the ischiums. It is the difference between the position measured before and after 1 hour of standardized activities.
Day 0 therefore before the implementation of the positioning actions then at Day 1 and Day 7
Evolution of the score on the TAWC scale
Time Frame: Day 0 therefore before the implementation of the positioning actions then at Day 7

The TAWC (Tool for Assessing Wheelchair discomfort) scale assesses 2 discomfort scores:

  • an assessment of general discomfort, based on 13 items scored on 7 points
  • an evaluation of the intensity of the discomfort, based on 9 items from 0 to 10.
Day 0 therefore before the implementation of the positioning actions then at Day 7
Evolution of the caregiver questionnaire score (Likert scale)
Time Frame: Day 0 therefore before the implementation of the positioning actions then at Day 7
Day 0 therefore before the implementation of the positioning actions then at Day 7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Jean Gabriel PREVINAIRE, MD, Fondation Hopale

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2023

Primary Completion (Estimated)

December 15, 2023

Study Completion (Estimated)

December 22, 2023

Study Registration Dates

First Submitted

November 10, 2022

First Submitted That Met QC Criteria

December 8, 2022

First Posted (Actual)

December 16, 2022

Study Record Updates

Last Update Posted (Actual)

August 31, 2023

Last Update Submitted That Met QC Criteria

August 30, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HOP-RIPH2-21-05

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neurological Disease

Clinical Trials on Choice and adjustment of the wheelchair according to the patient's needs

Subscribe